Saborowski, A., Lehmann, U., & Vogel, A. (2020). FGFR inhibitors in cholangiocarcinoma: What’s now and what’s next? Ther Adv Med Oncol.
Citación estilo ChicagoSaborowski, Anna, Ulrich Lehmann, y Arndt Vogel. "FGFR Inhibitors in Cholangiocarcinoma: What’s Now and What’s Next?" Ther Adv Med Oncol 2020.
Cita MLASaborowski, Anna, Ulrich Lehmann, y Arndt Vogel. "FGFR Inhibitors in Cholangiocarcinoma: What’s Now and What’s Next?" Ther Adv Med Oncol 2020.
Precaución: Estas citas no son 100% exactas.